Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars

Resource Tag: DR-TB

Operational guidance on service delivery to TB patients (drug-susceptible and drug-resistant) during the COVID-19 pandemic

Operational guidance on service delivery to TB patients (drug-susceptible and drug-resistant) during the COVID-19 pandemic
Author(s): Infectious Disease Society of Southern Africa
Year: 2020
Filed under: Coronavirus, COVID-19, DR-TB, Drug-resistant TB, Guidance, Guidance and Tools, Service delivery, TB care, TB patients
Continue Reading

Community-based Care for Drug-resistant Tuberculosis: A Guide for Implementers

Community-based Care for Drug-resistant Tuberculosis: A Guide for Implementers
Author(s): TB Care II
Year: 2017
Filed under: Community, DR-TB, Drug-resistant TB, Guidance, Guidance and Tools, Program plannning, TB care, Technical Guidance
Continue Reading

Management of drug-resistant tuberculosis

Management of drug-resistant tuberculosis
Author(s): The Lancet
Year: 2019
Filed under: DR-TB, Drug-resistant TB, mdr-tb, multidrug-resistant TB, Mycobacterium, TB patients, Treatment
Continue Reading

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis
Author(s): Trials
Year: 2014
Filed under: Diagnosis, DR-TB, Drug-resistant TB, Journal Article, Rapid tests, Research, XDR-TB
Continue Reading

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
Author(s): BMC Public Health
Year: 2015
Filed under: DR-TB, Drug-resistant TB, Journal Article, Research, Review, Risk, Sub-Saharan Africa, TB patients
Continue Reading

Innovative approach to the design and evaluation of treatment adherence interventions for drug-resistant TB

Innovative approach to the design and evaluation of treatment adherence interventions for drug-resistant TB
Filed under: Design, DR-TB, Drug-resistant TB, Evaluation, Innovation, Intervention, Journal Article, Research, Treatment
Continue Reading

Cost analysis of rapid diagnostics for drug-resistant tuberculosis

Cost analysis of rapid diagnostics for drug-resistant tuberculosis
Author(s): BMC Infectious Diseases
Year: 2018
Filed under: Cost, Diagnostics, DR-TB, Drug-resistant TB, Journal Article, Research, Testing, XDR-TB
Continue Reading

Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa

Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa
Author(s): Proceedings of the National Academy of Sciences
Year: 2019
Filed under: DR-TB, Drug-resistant TB, HIV, Journal Article, Mycobacterium, Research, South Africa, XDR
Continue Reading

Prevalence and patterns of drug resistant pulmonary tuberculosis in India—A systematic review and meta-analysis

Prevalence and patterns of drug resistant pulmonary tuberculosis in India—A systematic review and meta-analysis
Author(s): Journal of Global Antimicrobial Resistance
Year: 2020
Filed under: DR-TB, Drug-resistant TB, Epidemiology, Journal Article, MDR, Pulmonary tuberculosis, Research, TB control
Continue Reading

Posts navigation

Newer Posts
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.